Gastrointestinal Microbiota Impacts Human Health and Disease 2.0
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Gut Microbiota".
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 1583
Special Issue Editor
2. Riddet Institute, Massey University, Palmerston North 4442, New Zealand
Interests: human gastrointestinal microbiota; food-microbiota; health and disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is a continuation of our 2019 Special Issue "Gastrointestinal Microbiota Impacts Human Health and Disease".
A huge abundance and diversity of microorganisms that colonize different regions of the human gastrointestinal tract participate in a range of metabolic activities and influence many aspects of health and disease. They play an important role in maintaining immune homeostasis, assist in energy harvest from non-digestible dietary components through fermentation in the large intestine and generate many bioactive metabolites, such as short-chain fatty acids. Equally, dysbiosis is associated with a number of diseases including inflammatory bowel disease, diabetes mellitus, obesity and metabolic syndrome. Gut microbiome research has been revolutionised over the past decade through the development of culture-independent, high-throughput, next-generation DNA sequencing technology. We are developing a much better understanding of the composition of microbial communities of the healthy human gut, defining dominant members. The application of multiple omic technologies such metabolomics, proteomics, and transcriptomics has further enhanced our ability to decipher the function of the human gut microbiome including its interaction with the human host and impact on health. It is now well known that diet is one of the major influencers of both the short- and long-term composition of the human gut microbiome. Dietary manipulation of the gut microbiome therefore offers an attractive approach to achieve favourable health outcomes.
Dr. Pramod Gopal
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gastrointestinal health
- gut microbiome
- gut–brain axis
- probiotics
- prebiotics
- IBD
- IBS
- gut inflammation
- gut comfort
- gut function
- SCFA
- oligosaccharides
